PL
RYTM icon

Parkwood LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Parkwood LLC’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,387
Closed -$673K – 128
2024
Q2 		$673K Buy
16,387
+1,354
+9% +$54K 0.08% 105
2024
Q1 		$651K Buy
15,033
+4,835
+47% +$212K 0.06% 159
2023
Q4 		$469K Buy
+10,198
New +$322K 0.06% 101
2023
Q2 		– Sell
-19,147
Closed -$342K – 162
2023
Q1 		$342K Buy
19,147
+1,601
+9% +$40.2K 0.05% 129
2022
Q4 		$511K Buy
+17,546
New +$451K 0.08% 108

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkwood LLC's RYTM Position: Q3 2024 in Review

Parkwood LLC sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2024, closing a stake of 16,387 shares — an estimated $673K sold.

Parkwood LLC first reported a position in RYTM in Q4 2022 and held it in 5 quarters. The position peaked at $673K in Q2 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • Parkwood LLC reported no remaining Rhythm Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 16,387 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $673K.
  • Parkwood LLC first reported a position in Rhythm Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Parkwood LLC's Rhythm Pharmaceuticals position peaked at $673K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.